Zacras azilsartan/amlodipine besylate regulatory update

Takeda said Japan's Ministry of Health, Labor and Welfare (MHLW) approved an NDA for Zacras, a fixed-dose combination of azilsartan and amlodipine besylate, to treat hypertension. Azilva azilsartan, ...